Strategic guidance for technical founders in biotech
Hey {{first_name|default:there}}, it’s Vadim 👋
Welcome back to the Investor Sourcing Intensive!
Last week, we introduced the SIFT System: your 4-step framework to go from scattered to strategic:
Source → Isolate → Filter → Tier
Hopefully you were able to build your foundation list (200-300 names) and set up your tracking system (let me know how it went!). Now it's time to go deeper.
This week, we're diving into your most accessible capital source as a pre-seed or seed-stage biotech founder: angels and angel groups.
Here's what we'll cover:
The difference between individual angels and angel groups (and why it can be helpful to have both on your cap table)
Where to actually find biotech-savvy angels, not just "wealthy people who like startups"
The angel group landscape: which ones focus on life sciences and are worth your time
How to apply SIFT to qualify angels before you waste months pitching the wrong ones
Red flags that signal a tire-kicker vs. a real check-writer
Stick around until the end - I'm including a curated directory of 50+ angel groups that actually invest in life sciences, plus a few other resources to save you hours of research.
Now, brew your most potent hot chocolate, and let’s dive in 🙂